Paula Soteropoulos, Chief Executive Officer at AKCEA THERAPEUTICS, INC. (AKCA), sold 36,772 shares at $32.14 ($1.2M) on 2019-03-06, disclosed to the SEC on 2019-03-07.
Open-market sale of $1.2M AKCA by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.14 | 18,386 | $591K | 50.0% |
| 2 | $32.14 | 18,386 | $591K | 50.0% |
| Total | $32.14 avg | 36,772 | $1.2M | 100% |
| Filing → |
| DNTH | SELL | 2026-03-26 | $2.2M | — | Filing → |
| QURE | SELL | 2024-06-17 | $11K | — | Filing → |
| QURE | SELL | 2023-06-20 | $43K | — | Filing → |